Patents by Inventor Elliott A. Milstein

Elliott A. Milstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9408786
    Abstract: A composition for the treatment of skin comprises a non-emulsified, aqueous suspension of retinol. The composition may further include at least one protein species, and some proteins used in the composition include collagen and elastin. The composition may also include hyaluronic acid. The composition may also include one or more of tocopheryl acetate, propylene glycol, and linseed extract. Also disclosed are methods for making the composition and use of the composition for the treatment of skin.
    Type: Grant
    Filed: May 28, 2013
    Date of Patent: August 9, 2016
    Assignee: Biopelle, Inc.
    Inventor: Elliott Milstein
  • Publication number: 20130259915
    Abstract: A composition for the treatment of skin comprises a non-emulsified, aqueous suspension of retinol. The composition may further include at least one protein species, and some proteins used in the composition include collagen and elastin. The composition may also include hyaluronic acid. The composition may also include one or more of tocopheryl acetate, propylene glycol, and linseed extract. Also disclosed are methods for making the composition and use of the composition for the treatment of skin.
    Type: Application
    Filed: May 28, 2013
    Publication date: October 3, 2013
    Inventor: Elliott Milstein
  • Patent number: 5670547
    Abstract: A formulation containing tretinoin, a gelling agent, proteinaceous material, and water is provided for the uniform topical application of tretinoin. The water-based formulation is oil- and fat-free, alcohol-free, and rich in proteinaceous material. The formulation is stable over time and is comedogenic and less irritating and drying to the skin.
    Type: Grant
    Filed: April 26, 1995
    Date of Patent: September 23, 1997
    Assignee: Dow Pharmaceutical Sciences
    Inventors: Elliott A. Milstein, Nathan Milstein